Contact
searchSearch
HMP Global
Login

Abstracts Topic Center

Abstracts
Clinical Benefits and Commonly Reported Adverse Events and Their Associated Costs in Patients With Chronic Lymphocytic Leukemia Treated With Bruton Tyrosine Kinase Inhibitors in First-Line and Relapsed/Refractory Settings
08/23/2024
Ibrutinib, acalabrutinib, and zanubrutinib are Bruton tyrosine kinase inhibitors (BTKis) approved for treatment of chronic lymphocytic leukemia (CLL). In this study, researchers used data from package inserts, clinical trials, and real-world...
Ibrutinib, acalabrutinib, and zanubrutinib are Bruton tyrosine kinase inhibitors (BTKis) approved for treatment of chronic lymphocytic leukemia (CLL). In this study, researchers used data from package inserts, clinical trials, and real-world...
Ibrutinib, acalabrutinib, and...
08/23/2024
Journal of Clinical Pathways
Abstracts
The Impact in Quality of Life of Adverse Events With Systemic Therapies for Metastatic Colorectal Cancer Previously Treated With Standard Therapies and Biologics in the United States
08/23/2024
Systemic therapies for metastatic colorectal cancer (mCRC) have distinct safety and tolerability profiles. Adverse events (AEs) may occur and compromise the course of treatment, increase health care utilization and costs, and worsen patients’...
Systemic therapies for metastatic colorectal cancer (mCRC) have distinct safety and tolerability profiles. Adverse events (AEs) may occur and compromise the course of treatment, increase health care utilization and costs, and worsen patients’...
Systemic therapies for...
08/23/2024
Journal of Clinical Pathways
Abstracts
The Economic Impact of Vial Sizes on Drug Waste of Bortezomib and Carfilzomib in Multiple Myeloma: The US Oncology Network Study
08/23/2024
Drug waste poses a significant challenge in the field of health care, resulting in increased costs and environmental concerns. Using administrative claims data for Medicare patients from 15 practices in The US Oncology Network, researchers...
Drug waste poses a significant challenge in the field of health care, resulting in increased costs and environmental concerns. Using administrative claims data for Medicare patients from 15 practices in The US Oncology Network, researchers...
Drug waste poses a significant...
08/23/2024
Journal of Clinical Pathways
Abstracts
Ready or Not: Assessment of Readiness for Oncology Value-Based Care Program Participation
08/23/2024
Conducting a thorough and systemic evaluation of practice readiness for value-based care (VBC) programs empowers practices to make informed decisions about VBC model participation. VBC programs like the Enhancing Oncology Model (EOM) offers...
Conducting a thorough and systemic evaluation of practice readiness for value-based care (VBC) programs empowers practices to make informed decisions about VBC model participation. VBC programs like the Enhancing Oncology Model (EOM) offers...
Conducting a thorough and...
08/23/2024
Journal of Clinical Pathways
Abstracts
Beyond the Diagnosis: Exploring the Multifaceted Distress Profile of Patients With Cancer
08/23/2024
To fully understand and rectify impediments to optimal patient outcomes and experiences for patients with cancer, researchers reviewed health-related social needs (HRSN) to fully understand how to provide support to affected patients....
To fully understand and rectify impediments to optimal patient outcomes and experiences for patients with cancer, researchers reviewed health-related social needs (HRSN) to fully understand how to provide support to affected patients....
To fully understand and rectify...
08/23/2024
Journal of Clinical Pathways
Abstracts
A Pilot Program of Automated Patient Identification for Survivorship Resources Using Clinical Oncology Pathways
08/23/2024
Manual electronic health records (EHR) can help bridge the gap between patients with cancer and survivorship resources. In this study, researchers conducted a pilot using a web-based clinical pathways decision-support platform to provide...
Manual electronic health records (EHR) can help bridge the gap between patients with cancer and survivorship resources. In this study, researchers conducted a pilot using a web-based clinical pathways decision-support platform to provide...
Manual electronic health records...
08/23/2024
Journal of Clinical Pathways
Abstracts
Claims Payment Status for On-Pathway Navigations Across an Academic Cancer Center and its Network
08/23/2024
Delays in cancer treatment authorization often impede optimal patient care. In this retrospective assessment of payment rates, the Dana-Farber Cancer Institute explores payer approval decisions for on-pathway treatments.
Delays in cancer treatment authorization often impede optimal patient care. In this retrospective assessment of payment rates, the Dana-Farber Cancer Institute explores payer approval decisions for on-pathway treatments.
Delays in cancer treatment...
08/23/2024
Journal of Clinical Pathways
Abstracts
Impact of an EHR-Embedded Clinical Decision Support (CDS) Tool on Guideline Adoption: A Retrospective Analysis of Clinician Adaptation to Treatment Intensification in Prostate Cancer
08/23/2024
According to research published in the Journal of Clinical Oncology, clinical decision support (CDS) tools can foster an accelerated uptake of new therapies compared to non-users. In this study, researchers used a CDS tool called Flatiron...
According to research published in the Journal of Clinical Oncology, clinical decision support (CDS) tools can foster an accelerated uptake of new therapies compared to non-users. In this study, researchers used a CDS tool called Flatiron...
According to research published...
08/23/2024
Journal of Clinical Pathways
Abstracts
Building an Episode of Care to Reduce Time to Treatment
08/23/2024
When previously identifying causes of delay in cancer treatment, existing workflows often did not provide consistent timelines estimated for providers to diagnose and treat patients. To reduce time to treatment, researchers employed a pilot...
When previously identifying causes of delay in cancer treatment, existing workflows often did not provide consistent timelines estimated for providers to diagnose and treat patients. To reduce time to treatment, researchers employed a pilot...
When previously identifying...
08/23/2024
Journal of Clinical Pathways
Abstracts
Iris: Using a Telehealth Platform to Provide Virtual Supportive Care for Patients in Oncology
08/23/2024
Telehealth technologies are emerging as transformative tools in health care. Implementing telehealth strategies allows providers to bridge the gap between access to support services, improving patient outcomes and overall experience. In a...
Telehealth technologies are emerging as transformative tools in health care. Implementing telehealth strategies allows providers to bridge the gap between access to support services, improving patient outcomes and overall experience. In a...
Telehealth technologies are...
08/23/2024
Journal of Clinical Pathways
Abstracts
Clinical Benefits and Commonly Reported Adverse Events and Their Associated Costs in Patients With Chronic Lymphocytic Leukemia Treated With Bruton Tyrosine Kinase Inhibitors in First-Line and Relapsed/Refractory Settings
08/23/2024
Ibrutinib, acalabrutinib, and zanubrutinib are Bruton tyrosine kinase inhibitors (BTKis) approved for treatment of chronic lymphocytic leukemia (CLL). In this study, researchers used data from package inserts, clinical trials, and real-world...
Ibrutinib, acalabrutinib, and zanubrutinib are Bruton tyrosine kinase inhibitors (BTKis) approved for treatment of chronic lymphocytic leukemia (CLL). In this study, researchers used data from package inserts, clinical trials, and real-world...
Ibrutinib, acalabrutinib, and...
08/23/2024
Journal of Clinical Pathways
Abstracts
The Impact in Quality of Life of Adverse Events With Systemic Therapies for Metastatic Colorectal Cancer Previously Treated With Standard Therapies and Biologics in the United States
08/23/2024
Systemic therapies for metastatic colorectal cancer (mCRC) have distinct safety and tolerability profiles. Adverse events (AEs) may occur and compromise the course of treatment, increase health care utilization and costs, and worsen patients’...
Systemic therapies for metastatic colorectal cancer (mCRC) have distinct safety and tolerability profiles. Adverse events (AEs) may occur and compromise the course of treatment, increase health care utilization and costs, and worsen patients’...
Systemic therapies for...
08/23/2024
Journal of Clinical Pathways
Abstracts
The Economic Impact of Vial Sizes on Drug Waste of Bortezomib and Carfilzomib in Multiple Myeloma: The US Oncology Network Study
08/23/2024
Drug waste poses a significant challenge in the field of health care, resulting in increased costs and environmental concerns. Using administrative claims data for Medicare patients from 15 practices in The US Oncology Network, researchers...
Drug waste poses a significant challenge in the field of health care, resulting in increased costs and environmental concerns. Using administrative claims data for Medicare patients from 15 practices in The US Oncology Network, researchers...
Drug waste poses a significant...
08/23/2024
Journal of Clinical Pathways
Abstracts
Ready or Not: Assessment of Readiness for Oncology Value-Based Care Program Participation
08/23/2024
Conducting a thorough and systemic evaluation of practice readiness for value-based care (VBC) programs empowers practices to make informed decisions about VBC model participation. VBC programs like the Enhancing Oncology Model (EOM) offers...
Conducting a thorough and systemic evaluation of practice readiness for value-based care (VBC) programs empowers practices to make informed decisions about VBC model participation. VBC programs like the Enhancing Oncology Model (EOM) offers...
Conducting a thorough and...
08/23/2024
Journal of Clinical Pathways
Abstracts
Beyond the Diagnosis: Exploring the Multifaceted Distress Profile of Patients With Cancer
08/23/2024
To fully understand and rectify impediments to optimal patient outcomes and experiences for patients with cancer, researchers reviewed health-related social needs (HRSN) to fully understand how to provide support to affected patients....
To fully understand and rectify impediments to optimal patient outcomes and experiences for patients with cancer, researchers reviewed health-related social needs (HRSN) to fully understand how to provide support to affected patients....
To fully understand and rectify...
08/23/2024
Journal of Clinical Pathways
Abstracts
A Pilot Program of Automated Patient Identification for Survivorship Resources Using Clinical Oncology Pathways
08/23/2024
Manual electronic health records (EHR) can help bridge the gap between patients with cancer and survivorship resources. In this study, researchers conducted a pilot using a web-based clinical pathways decision-support platform to provide...
Manual electronic health records (EHR) can help bridge the gap between patients with cancer and survivorship resources. In this study, researchers conducted a pilot using a web-based clinical pathways decision-support platform to provide...
Manual electronic health records...
08/23/2024
Journal of Clinical Pathways
Abstracts
Claims Payment Status for On-Pathway Navigations Across an Academic Cancer Center and its Network
08/23/2024
Delays in cancer treatment authorization often impede optimal patient care. In this retrospective assessment of payment rates, the Dana-Farber Cancer Institute explores payer approval decisions for on-pathway treatments.
Delays in cancer treatment authorization often impede optimal patient care. In this retrospective assessment of payment rates, the Dana-Farber Cancer Institute explores payer approval decisions for on-pathway treatments.
Delays in cancer treatment...
08/23/2024
Journal of Clinical Pathways
Abstracts
Impact of an EHR-Embedded Clinical Decision Support (CDS) Tool on Guideline Adoption: A Retrospective Analysis of Clinician Adaptation to Treatment Intensification in Prostate Cancer
08/23/2024
According to research published in the Journal of Clinical Oncology, clinical decision support (CDS) tools can foster an accelerated uptake of new therapies compared to non-users. In this study, researchers used a CDS tool called Flatiron...
According to research published in the Journal of Clinical Oncology, clinical decision support (CDS) tools can foster an accelerated uptake of new therapies compared to non-users. In this study, researchers used a CDS tool called Flatiron...
According to research published...
08/23/2024
Journal of Clinical Pathways
Abstracts
Building an Episode of Care to Reduce Time to Treatment
08/23/2024
When previously identifying causes of delay in cancer treatment, existing workflows often did not provide consistent timelines estimated for providers to diagnose and treat patients. To reduce time to treatment, researchers employed a pilot...
When previously identifying causes of delay in cancer treatment, existing workflows often did not provide consistent timelines estimated for providers to diagnose and treat patients. To reduce time to treatment, researchers employed a pilot...
When previously identifying...
08/23/2024
Journal of Clinical Pathways
Abstracts
Iris: Using a Telehealth Platform to Provide Virtual Supportive Care for Patients in Oncology
08/23/2024
Telehealth technologies are emerging as transformative tools in health care. Implementing telehealth strategies allows providers to bridge the gap between access to support services, improving patient outcomes and overall experience. In a...
Telehealth technologies are emerging as transformative tools in health care. Implementing telehealth strategies allows providers to bridge the gap between access to support services, improving patient outcomes and overall experience. In a...
Telehealth technologies are...
08/23/2024
Journal of Clinical Pathways

BDHC Thumbnail
Videos
Alternative Payment Models in Health Care: Successes, Failures, and What’s Next
01/09/2025
In this Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, discuss the evolution and challenges of alternative payment models, including accountable care organizations (ACOs), the Oncology Care Model (OCM),...
In this Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, discuss the evolution and challenges of alternative payment models, including accountable care organizations (ACOs), the Oncology Care Model (OCM),...
In this Breaking Down Health...
01/09/2025
Cancer Care Business Exchange
BDHC thumbnail
Videos
Precision Medicine in Oncology: From Testing to Therapy
12/05/2024
In this Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, explore the distinction between precision and personalized medicine, the challenges and nuances of next-generation sequencing (NGS) testing in...
In this Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, explore the distinction between precision and personalized medicine, the challenges and nuances of next-generation sequencing (NGS) testing in...
In this Breaking Down Health...
12/05/2024
Cancer Care Business Exchange
Videos
Driving Innovation in Cancer Care: The Future of Value-Based Care in Oncology
12/04/2024
In this interview, Gordon Kuntz discusses the Delphi Method, a Predictable Cost of Care Model developed by the Predictable Cost of Care Working Group that enhances oncology market access strategies by standardizing and broadening the economic...
In this interview, Gordon Kuntz discusses the Delphi Method, a Predictable Cost of Care Model developed by the Predictable Cost of Care Working Group that enhances oncology market access strategies by standardizing and broadening the economic...
In this interview, Gordon Kuntz...
12/04/2024
Journal of Clinical Pathways
Videos
Building Consensus for Predictable Cancer Care Costs: Applying the Delphi Method to Multidisciplinary Stakeholder Collaboration
12/02/2024
In this interview, Carole Tremonti, RN, MBA, discusses the critical role of clinical pathways in equitable cancer care, the application of the Delphi Method by the Predictable Cost of Care Working Group to foster multidisciplinary...
In this interview, Carole Tremonti, RN, MBA, discusses the critical role of clinical pathways in equitable cancer care, the application of the Delphi Method by the Predictable Cost of Care Working Group to foster multidisciplinary...
In this interview, Carole...
12/02/2024
Journal of Clinical Pathways
Videos
The Evolving Role of Pharmacists in Custom Pathway Implementation
11/25/2024
In this interview, Rebecca Maniago, PharmD, discusses the complexities of implementing custom clinical pathways, emphasizing the need for clear goals, robust resources, and ongoing updates, while highlighting the pivotal role of pharmacists...
In this interview, Rebecca Maniago, PharmD, discusses the complexities of implementing custom clinical pathways, emphasizing the need for clear goals, robust resources, and ongoing updates, while highlighting the pivotal role of pharmacists...
In this interview, Rebecca...
11/25/2024
Journal of Clinical Pathways

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use